Progetti FP7 coordinati da "Medizinische universitaet wien"
| # | ||||
|---|---|---|---|---|
| 1 | TOBI Targeting OBesity-driven Inflammation | 2008 | 3˙862˙481.00 | 2˙980˙964.00 |
| 2 | RESOLVE Resolve Chronic Inflammation and Achieve Healthy Aging by Understanding Non-regenerative Repair | 2008 | 14˙173˙960.00 | 10˙689˙714.00 |
| 3 | TH2MEMORY Identification of key chemokine-chemokine receptor interactions that control the memory Th2 cells in allergic asthma | 2008 | 227˙092.00 | 227˙092.00 |
| 4 | GMSAFOOD Biomarkers for post market monitoring of short and long-term effects of genetically modified organisms (GMOs) on animal and human health | 2008 | 3˙424˙810.00 | 2˙606˙622.00 |
| 5 | ADENOSINE-RECEPTOR Identification of the protein interactome of the A2A-adenosine receptor | 2008 | 100˙000.00 | 100˙000.00 |
| 6 | INFARCT CELL THERAPY Therapy after heart infarct: prevention of reperfusion injury and repair by stem cell transfer | 2009 | 3˙567˙100.00 | 2˙700˙000.00 |
| 7 | EPIGENETIC MARKER Evaluation of epigenetic biomarkers in prostate cancer patients before and after hormone ablation therapy | 2009 | 75˙000.00 | 75˙000.00 |
| 8 | TRANSVIR Translational Science for Vascular Inflammation and Remodelling | 2009 | 2˙677˙767.00 | 2˙677˙767.00 |
| 9 | HIPPOCHRONOCIRCUITRY The chronocircuitry of the hippocampus during cognitive behaviour | 2010 | 1˙760˙911.00 | 1˙760˙911.00 |
| 10 | ROBOGYN Robotic Gynecological Brachytherapy | 2010 | 113˙186.00 | 113˙186.00 |
| 11 | INTRICATE Infectious triggers of chronic autoimmunity | 2010 | 7˙764˙663.00 | 5˙965˙086.00 |
| 12 | 3D3CSI Three-dimensional Clinical Coherent Chemically-sensitive Imaging | 2011 | 170˙481.00 | 170˙481.00 |
| 13 | MULTIFACETED CASR "The role of the Calcium Sensing Receptor (CaSR) in health and disease, implications for translational medicine." | 2011 | 2˙915˙948.00 | 2˙915˙948.00 |
| 14 | ENEPIA "ENvironment, EPigenetics and the Initiation of Allergic asthma" | 2011 | 244˙190.00 | 244˙190.00 |
| 15 | ALCHEMVIENNA "Alchemical Manuscripts in Medical Vienna, 14th-17th century" | 2011 | 156˙422.00 | 156˙422.00 |
| 16 | HTDDSFMT HIGH THROUGHPUT DRUG DISCOVERY STUDIES FOR MENINGIOMA THERAPEUTICS | 2011 | 100˙000.00 | 100˙000.00 |
| 17 | PROT-HISPRA HIgh Speed PRoteomics Analysis (Prot-HiSPRA): Solving the bottlenecks of proteomics technologies for time sensitive proteome driven medical decisions | 2011 | 3˙212˙398.00 | 2˙536˙246.00 |
| 18 | ATOPICA "Atopic diseases in changing climate, land use and air quality" | 2011 | 4˙426˙870.00 | 3˙497˙160.00 |
| 19 | NPC GENEXPRESS The nuclear pore connection: adaptor complexes bridging genome regulation and nuclear transport | 2011 | 1˙481˙556.00 | 1˙481˙556.00 |
| 20 | DEVELAGE Pathways common to brain development and ageing: defining strategies for preventive therapy and diagnostics | 2012 | 3˙881˙830.00 | 2˙994˙137.00 |
| 21 | OCTIPS Ovarian Cancer Therapy – Innovative Models Prolong Survival | 2012 | 3˙964˙946.00 | 2˙999˙302.00 |
| 22 | PU.1 ANTISENSE ROLE OF ANTISENSE RNAs ON PU.1 REGULATION AND HEMATOPOIESIS | 2012 | 245˙962.00 | 245˙962.00 |
| 23 | BONEMATCH Bone Multi-modal Automated Trabecular Histomorphometry | 2012 | 183˙606.00 | 183˙606.00 |
| 24 | FAMOS Functional anatomical molecular optical screening | 2012 | 13˙404˙446.00 | 10˙099˙999.00 |
| 25 | LOAD PROFILE Development of a late-onset-Alzheimer’s disease (LOAD) profile for accurate diagnosis and identification of potential therapeutic approaches | 2012 | 747˙300.00 | 747˙300.00 |
| 26 | LASAGNE multi-LAyer SpAtiotemporal Generalized NEtworks | 2012 | 2˙733˙858.00 | 2˙075˙000.00 |
| 27 | GATA3 IN KIDNEY The role of the transcription factor GATA3 in kidney function and disease | 2013 | 187˙888.00 | 187˙888.00 |
| 28 | FABRIC Exploring the Formation and Adaptation of the Brain Connectome | 2013 | 179˙137.00 | 179˙137.00 |
| 29 | IMRESFUN Molecular Mechanisms of Fungal Pathogen Host Interactions | 2013 | 3˙591˙515.00 | 3˙591˙515.00 |
| 30 | MIR182_KIDNEY-TX miR-182 as new Therapeutical Target in Renal Transplantation | 2014 | 261˙326.00 | 261˙326.00 |
| 31 | CLL_INCLONEL Identification and functional dissection of key genetic events in early chronic lymphocytic leukemia | 2014 | 260˙874.00 | 260˙874.00 |
| 32 | ASRNABIDOPHYS Identification of light signaling components in the regulation of alternative splicing in plants | 2014 | 186˙783.00 | 186˙783.00 |
| 33 | CARAMEL "Impact of food matrix interaction and post-translational modifications on the allergenicity of Mal d 3, a major apple allergen" | 2015 | 240˙733.00 | 240˙733.00 |
Altri progetti
L'Ente medizinische universitaet wien partecipato anche in questi progetti.
- SUMMER (2012, participant)
- NPC GENEXPRESS (2011, hostInstitution)
- INNOVABONE (2011, participant)
- ARTIVASC 3D (2011, participant)
- CRISIS (2011, participant)
- OSTEOGROW (2012, participant)
- EUTRIPD (2011, participant)
- ECRIN-IA (2012, participant)
- MAN4GEN (2012, participant)
- CELLEUROPE (2012, participant)
- IT-LIVER (2012, participant)
- AQUAVALENS (2013, participant)
- NEUROKINE (2013, participant)
- NATURIMMUN (2012, participant)
- EURO-TEAM (2012, participant)
- VISCERAL (2012, participant)
- MULTIPLEX (2012, participant)
- VPH-PRISM (2013, participant)
- ESMART (2014, participant)
- IDEAL (2013, participant)
- KIDNEYCONNECT (2013, participant)
- FIBRO-TARGETS (2013, participant)
- INSPIRE (2014, participant)
- LENA (2013, participant)
- ASTERIX (2013, participant)
- EPISTOP (2013, participant)
- DIONICOS (2014, participant)
- GANNET53 (2013, participant)
- BIOPSYPEN (2013, participant)
- VIA (2013, participant)
- FUNGITECT (2014, participant)
- CREAM (2013, participant)
- PAINCAGE (2014, participant)
- RAREDISEASEPLATFORM (2008, participant)
- FUN OCT (2008, participant)
- ECRIN-PPI (2008, participant)
- NEUROCYPRES (2008, participant)
- AHEAD III (2008, participant)
- UNICELLSYS (2008, participant)
- EURIPIDES (2008, participant)
- EURIPFNET (2008, participant)
- ICREL (2008, participant)
- FAST (2008, participant)
- MASTERSWITCH (2008, participant)
- MOBI-KIDS (2009, participant)
- ENCE-CF-LAM-LTX (2009, participant)
- HYPERLAB (2009, participant)
- P3AGI (2009, participant)
- APRES (2009, participant)
- VBC ERN (2009, participant)
- ULICE (2009, participant)
- LIFEVALVE (2009, participant)
- NANOFOL (2009, participant)
- SYSKID (2010, participant)
- HIPPOCHRONOCIRCUITRY (2010, hostInstitution)
- HIPPOCHRONOCIRCUITRY (2010, hostInstitution)
- ISPACE (2009, participant)
- FLIP (2010, participant)
- DALI (2010, participant)
- ENVISION (2010, participant)
- PASODOBLE (2010, participant)
- EU-GEI (2010, participant)
- KHRESMOI (2010, participant)
- CYTOTHREAT (2011, participant)
- ACADEMIC GMP (2010, participant)
- MEDALL (2010, participant)
- PREDICTA (2010, participant)
- ENGCABRA (2011, participant)
- BARDIAG (2010, participant)
- FLU-PHARM (2010, participant)
- RESTORE (2011, participant)
- EUROCSCTRAINING (2011, participant)
- HURAPRIM (2011, participant)
- LEUKOTREAT (2010, participant)
- INSITE (2011, participant)